Zobrazeno 1 - 10
of 19
pro vyhledávání: '"L. F. de Leij"'
Autor:
Y. Stienstra, W. T. A. van der Graaf, G. J. te Meerman, T. H. The, L. F. de Leij, T. S. van der Werf
Publikováno v:
Tropical Medicine & International Health, 6(7), 554-562. Wiley
Mycobacterium ulcerans disease, also known as Buruli ulcer (BU), is a disease of subcutaneous fat tissue. BU is prevalent in riverine and swamp areas of the tropical zone in Africa, Asia and South America, and a few scattered foci in Australia. The m
Autor:
P M, McLaughlin, M C, Harmsen, W H, Dokter, B J, Kroesen, H, van der Molen, M G, Brinker, H, Hollema, M H, Ruiters, C H, Buys, L F, de Leij
Publikováno v:
Cancer research. 61(10)
The human pancarcinoma-associated epithelial glycoprotein-2 (EGP-2), a M(r) 38,000 transmembrane antigen also known as 17-1A or Ep-CAM, is commonly used for targeted immunotherapy of carcinomas because it is strongly expressed by most carcinomas. EGP
Autor:
A, de Haan, A P, van den Berg, W, van der Bij, B G, Hepkema, E, Bruin-van Dijk, I, van der Gun, S P, Lems, M J, Slooff, E B, Haagsma, L F, de Leij, J, Prop
Publikováno v:
Transplantation. 71(6)
A decrease in donor-specific T cell precursor frequencies as seen late, one or more years, after transplantation is assumed to reflect transplantation tolerance, a condition important for long term acceptance of the allograft. However, such late decr
Publikováno v:
International journal of cancer. 91(1)
In the current study, we determined short-term pharmacokinetics and whole body distribution of elastase derived angiostatin [angiostatin(k1-3)] in rats after i.v. injection of radiolabelled protein. Since in gamma-camera studies, no tumor specific an
Publikováno v:
Journal of biomedical materials research. 54(2)
Subcutaneous implantation of biodegradable hexamethylenediisocyanate crosslinked dermal sheep collagen (HDSC) elicited little foreign-body reaction in mice in contrast to rats. If the factor(s) resulting in this minor foreign-body reaction are better
Publikováno v:
Journal of biomedical materials research. 52(3)
Before a biomaterial can be applied in the clinic, biocompatibility must be tested in in vivo models, by monitoring the foreign body reaction. In this study, we compared the foreign body reaction (FBR) to the biodegradable biomaterial hexamethylenedi
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(6)
Peripheral blood stem cell (PBSC) support in breast cancer patients allows high-dose chemotherapy, but tumor cell contamination of the PBSCs is a potential source of relapse. Specific carcinoma cell killing can be obtained by retargeting activated T
Publikováno v:
Transplantation. 69(8)
After solid organ transplantation most alloantigens are presented to the recipient's immune system by normal tissue cells, which can be considered to act as nonprofessional antigen-presenting cells (APC). It is well accepted that such nonprofessional
Autor:
A, de Haan, I, van der Gun, B G, Hepkema, W J, de Boer, W, van der Bij, L F, de Leij, J, Prop
Publikováno v:
Transplantation. 69(7)
Decreased in vitro T cell alloreactivity, demonstrated by decreased frequencies of peripheral blood donor-specific T cell precursors, may reflect a tolerant state after transplantation and lower the risk for development of chronic graft dysfunction.
Autor:
P M, McLaughlin, W, Helfrich, K, Kok, M, Mulder, S W, Hu, M G, Brinker, M H, Ruiters, L F, de Leij, C H, Buys
Publikováno v:
International journal of cancer. 85(6)
The UBE1L gene isolated from the chromosome 3p21 region has an extremely reduced level of mRNA in lung cancer. Sequence analysis showed a 45% homology to the human ubiquitin-activating enzyme E1 at the amino acid level. To further characterize the pr